Our first GMP manufacturing pilot launches in Boston, surrounded by the highest concentration of world-renowned cancer treatment centers in the country.

From here, REALM Bio provides dedicated advanced therapy manufacturing capacity to Boston-area hospitals, starting with investigator-initiated trials and academic cell therapy programs.

Partner hospitals handle the patient side. We manufacture. Dedicated ATMP manufacturing, built to accelerate clinical research and reduce the wait between diagnosis and cure.

As the Boston pilot lab proves the model, the network extends across New England. Hospitals throughout the region connect to our manufacturing capacity, and dedicated ¹REALM Advanced Health centers bring cell collection closer to patients who don't need to travel to Boston.

Patients stay local. Cells travel to us. Therapies return.

The clinical logistics backbone, including cold chain, depot services, and chain of custody, is already operational through our established sister company, Boston Labs.

The proven model replicates across the country. Each hub is a regional manufacturing center supporting its own network of hospital partners and clinical collection sites.

Boston · Atlanta · Chicago · Houston · Los Angeles

Together, these hubs form a national infrastructure, a hub-and-spoke network that brings manufacturing capacity within reach of every major cancer treatment region in the United States.

With the clinical model validated across multiple hubs, REALM Bio activates commercial manufacturing, producing FDA-approved therapies for pharma sponsors who need regional capacity.

Sponsors gain predictable manufacturing slots, faster enrollment, and access to patient populations across every US region. We bring manufacturing capacity directly to the institutions that treat patients, so they can focus on clinical care.

For patients, the wait gets shorter. And in this space, time is survival.

Where there was hope, we fulfill the promise.

REALM Bio establishes an entire biotech ecosystem where none existed before. Kenya and Rwanda become the first complete deployments: manufacturing, analytical testing, clinical logistics, regulatory alignment, and workforce training, built by and for the communities they serve.

For the first time, curative therapies don't just exist somewhere else. They arrive.

Abu Dhabi completes the initial global footprint, serving the Gulf region and connecting to the broader Middle East and South Asian corridor.

Every deployment runs on the same ¹REALM Unified Services model. Same quality systems. Same manufacturing standards. Same logistics backbone. Adapted to local regulatory requirements, embedded within partner hospitals, and staffed by locally trained teams.

One model. Every service. Global reach.

Latin America, we see you.

We See You.

www.realm.bio ← Replay